Neuraminidase inhibitors are antiviral drugs used to treat acute respiratory infections and influenza (a highly contagious viral infection that affects the respiratory system and is a major cause of morbidity and mortality) Zanamivir is approved for treatment of uncomplicated acute illness caused by influenza virus in persons aged greater than or equal to 12 years who have been symptomatic for no more than 2 days.